Lifestyle Medicine. This presentation will:

Size: px
Start display at page:

Download "Lifestyle Medicine. This presentation will:"

Transcription

1 Lifestyle Medicine This presentation will: Present the biological and environmental factors contributing to the obesity epidemic Discuss the lifestyle modification therapy for patients with obesity, prediabetes, and diabetes Outline the model for care of the overweight or obese patient, based on the comprehensive diabetes algorithm Explain the implications of lifestyle modification on the prevention of prediabetes and diabetes

2 Obesity Conceptual Framework Obesity directly and indirectly promotes, and/or causes, adverse health consequences. Current evidence indicates that obesity must be treated as a chronic, relapsing disease. 2 Seger JC et al. Obesity Algorithm, presented by the American Society of Bariatric Physicians, (Access = April 6, 2015). Jensen MD et al. Circulation. 2014;129(25 suppl 2):S102 S138.

3 Adverse Health and Social Consequences Associated With Obesity Physical Psychosocial Functional Cancer Depression Absenteeism from school or work Cardiovascular disease Discrimination Disability Cholestasis Low self-esteem Disqualification from active military/fire/police services Dyslipidemia Negative body image Low physical fitness level Gallbladder disease Negative stereotyping Mobility limitations Glucose intolerance and insulin resistance Social marginalization Reduced academic performance Hepatic steatosis Teasing and bullying Reduced productivity Hypertension Hyperuricemia and gout Menstrual abnormalities Orthopedic problems Reduction of cerebral blood flow Sleep apnea T2DM Unemployment 3 American Academy of Family Physicians. obesity-diagnosis-management.pdf. Accessed April 15, 2015.

4 Age-adjusted Relative Risk Relationship Between BMI and Risk of T2DM 100 Men Women <22 < BMI = body mass index. Chan JM et al. Diabetes Care. 1994;17(9): Colditz GA et al. Ann Intern Med. 1995;122(7): BMI (kg/m 2 )

5 Δ Blood Pressure (mm Hg) Δ Triglycerides (mg/dl) Δ A1C (%) Δ HDL Cholesterol (mg/dl) Weight Loss Reduces Cardiometabolic Risk Factors in Patients With Type 2 Diabetes Intensified Lifestyle Intervention, 8.6% Weight Loss Diabetes Support and Education, 0.7% Weight Loss 4 3 * * Systolic Diastolic * Randomized, controlled trial; n = 5145; Patients with type 2 diabetes, age >18 y; Mean ± SE Intensified lifestyle intervention (n = 2496) vs. diabetes support and education (n = 2463) therapy; *P<0.001 between groups Look AHEAD Research Group. Diabetes Care. 2007;30: * *

6 Obesity Classification: BMI B Patients with overweight/obesity = increased body fat (adiposity) Overweight and obesity classification: Body Mass Index (BMI) in kg/m 2 ACTION ITEM: Normal weight Overweight Class I obesity Class II obesity For all patients, calculate BMI at annual visits or more ( ) ( ) ( ) ( ) frequently and identify body weight classification. Class III obesity ( 40.0) 6 Seger JC et al. Obesity Algorithm, presented by the American Society of Bariatric Physicians, (Access = April 6, 2015).

7 Identification and Screening: BMI Is the Starting Point 2013 AHA/ACC/TOS Obesity Guidelines identify patients who need to lose weight Measure height and weight and calculate BMI at annual visits or more frequently for all patients Use BMI cut points to classify patients with overweight or obesity BMI is used as an estimate of increased adverse health consequences 7 ACC = American College of Cardiology; AHA = American Heart Association; TOS = The Obesity Society. Jensen MD et al. Circulation. 2014;129(25 suppl 2):S102 S138.

8 Obesity Classification: Waist Circumference (WC) B Patients with overweight/obesity = increased body fat (adiposity) Overweight and obesity classification: Waist Circumference (WC) ACTION ITEM: Measure Men abdominal WC at annual obesity visits or more Women frequently abdominal in obesity patients 40 in. ( 102 cm)* 35 in. ( 88 cm)* with overweight or obesity. 8 *Different WC abdominal obesity cutoff points may be appropriate for different races, such as 90 cm for Asian men and 80 cm for Asian women. Seger JC et al. Obesity Algorithm, presented by the American Society of Bariatric Physicians, (Access = April 6, 2015).

9 Treatment: Modest Weight Loss = Major Health Benefits B 5% weight loss 10% weight loss 15% weight loss 9 T2DM prevention With T2DM: better glycemic control/ medication reduction Improvement in urinary stress incontinence, mobility, joint pain, weight-related QOL Improvements in CVD risk factors (HDL-C, TG, BP) Previous improvements Sleep apnea Blackburn G. Obes Res. 1995;3(suppl 2):211s-216s. Foster GD et al. Arch Intern Med. 2009;169(17): Gregg EW et al. JAMA. 2012;308(23): Sjostrom L et al. J Intern Med. 2013;273(3): Christou NV et al. Surg Obes Relat Dis. 2008;4(6): Diabetes remission? Previous improvements CVD mortality All-cause mortality and reduction in cancer risk (with surgical weight loss) ACTION ITEM: Consider the benefits that a 5% to 10% weight loss will have on your patients with overweight or obesity.

10 Reduction in Mortality with Modest Weight Loss Effects of Weight Loss in Type 2 Diabetes Every kg of weight loss is associated with 3 to 4 months of improved survival In a prospective analysis of 5000 people with type 2 diabetes, 35% reported intentional weight loss; this subgroup experienced a 25% reduction in mortality over 12 years Alternately, a 5-kg weight gain increases coronary heart disease risk by 30% Lean ME, et al. Diabet Med. 1990;7: ; Williamson DF, et al. Diabetes Care. 2000;23: Anderson JW et al. J Am Coll Nutr. 2003;22:331-9.

11 Regulation of Body Weight Genes confer the potential for obesity Environment determines whether the potential is realized, and to what extent

12 Thrifty Genes Contribute to Morbid Obesity Genetic factors account for 80% of a person s tendency to develop obesity Thrifty genes are designed to protect us from starvation by allowing us to store large amounts of energy in the form of fat when food is abundant This is the first time in human history that food has been so abundant The age-old advantage of thrifty genes has been influenced by our unique environment to cause disease Kaplan L. Body Weight Regulation and Obesity. J Gastrointestinal Surgery 2003;7(4): Hales and Barker et al, Diabetologia (4;35: and 3;36:62-67)

13

14 The Toxic Environment High-Calorie Food is Highly palatable Near-ubiquitous Heavily advertised Supersized Inexpensive Brownell KD & Horgen KB. Food Fight. New York: McGraw-Hill; 2003.

15 Sedentary Lifestyles Examples Physical activity is To be avoided Nearly unnecessary Limited by infrastructure

16 Defining Interventional Criteria for Pre-Diabetes Impaired fasting plasma glucose (IFG) = mg/dl ( mmol/l) Impaired glucose tolerance (IGT) = mg/dl ( mmol/l) Metabolic Syndrome diagnosed by National Cholesterol Education Program (NCEP) criteria should be considered a pre-diabetes equivalent Predicts future diabetes better than IFG 3 of 5 criteria of the metabolic syndrome are sufficient for diagnosis Hemoglobin A1C = 5.5%-6.4% In the absence of unequivocal hyperglycemia, this result should be confirmed by repeat testing AACE. Endocrine Practice. 2011;17(2)1-53. American Diabetes Association. Diabetes Care Jan; 36(Suppl 1):S National Cholesterol Education Program. National Institute of Health. Sept AACE. Endocrine Practice. 2008;14(7):933.

17 ADA Recommendations for Diabetes Screening HbA1c 5.7%, impaired glucose tolerance (IGT) or impaired fasting glucose (IFG) on previous testing Polycystic ovary syndrome (PCOS) Other conditions associated with insulin resistance such as severe obesity or acanthosis nigricans Overweight children >10 years old (or after puberty onset if earlier) with 2 of family history of type 2 diabetes Signs of insulin resistance or conditions associated with insulin resistance (acanthosis nigricans, hypertension, dyslipidemia, or PCOS) Maternal history of diabetes or gestational diabetes Ethnic group at increased risk Repeat screening every 3 years if normal, or every year if at increased risk for future diabetes Test every 1-2 years if prediabetes is diagnosed and every 3 years if glucose tolerance is normal ADA. Diabetes Care. 2012;35:S11-S63.

18 Acanthosis Nigricans: A Sign of Insulin Resistance Velvety, lightbrown-to-black discoloration usually on the neck, back, axilla, groin, and dorsum of hands may point to PCOS in females Insulin sensitivity decreases by 30% at puberty with compensatory increase in insulin secretion Unger J. Diabetes Management in Primary Care, 2 nd ed. Philadelphia, PA: Lippincott, Williams & Wilkins; 2012.

19 What are the health risks associated with prediabetes? Progression to diabetes: on average, 11% of people with prediabetes develop type 2 diabetes each year (DPP) Other studies: majority with prediabetes develop type 2 diabetes in 10 years Presence of microvascular complications at onset of diabetes 50% higher risk of CVD,CAD and stroke DPP, Diabetes Prevention Program NDIC/NIDDK. Diabetes Prevention Program. Accessed May 1, 2013.

20 Interventions to Reduce the Risks Associated with Prediabetes Intensive lifestyle management is the cornerstone of all prevention efforts No pharmacologic agents are currently approved for the management of prediabetes Pharmacotherapy targeted at glucose may be considered in high risk patients after individual risk: benefit analysis

21 Diabetes Incidence per 100 Person-Years Intensive Lifestyle Intervention Prevents Progression From IGT to T2DM Diabetes Prevention Program (n=3234) 31% 58% Intensive lifestyle intervention* (n=1079) Metformin 850mg BID (n=1073) Placebo (n=1082) *Goal: 7% reduction in baseline body weight through low-calorie, low-fat meal plan and 150 min/week moderate intensity physical activity. IGT, impaired glucose tolerance; T2DM, type 2 diabetes mellitus.. DPP Research Group. N Engl J Med. 2002;346:

22 Components of Therapeutic Lifestyle Change Nutrition Reduced calorie diet Healthy eating Sufficient physical activity Avoidance of tobacco products Limited alcohol consumption Sufficient sleep Stress reduction (including behavioral therapy as necessary) Handelsman Y, et al. Endocr Pract. 2011;17(suppl 2):1-53.

23 Nutrition Nutritional Components Topic Recommendation Carbohydrate Understand health effects of the 3 types of carbohydrates: sugars, starch, and fiber Target 7-10 servings per day of healthful carbohydrates (fresh fruits and vegetables, pulses, whole grains) Lower-glycemic index foods may facilitate glycemic control:* multigrain bread, pumpernickel bread, whole oats, legumes, apple, lentils, chickpeas, mango, yams, brown rice Eat healthful fats: low-mercury/low-contaminant-containing nuts, avocado, certain plant oils, fish Fat Limit saturated fats (butter, fatty red meats, tropical plant oils, fast foods) and trans fats Use no- or low-fat dairy products Consume protein from foods low in saturated fats (fish, egg whites, beans) Protein Avoid or limit processed meats Routine supplementation not necessary except for patients at risk of insufficiency or deficiency Micronutrients Chromium; vanadium; magnesium; vitamins A, C, and E; and CoQ10 not recommended for glycemic control *Insufficient evidence to support a formal recommendation to educate patients that sugars have both positive and negative health effects Handelsman Y, et al. Endocr Pract. 2011;17(suppl 2):1-53.

24 Macronutrient Diet Composition Diets enriched in the following are associated with a decrease in insulin sensitivity Total fat Saturated fat Trans-fat Refined grains Diets enriched in the following are associated with an increase in insulin sensitivity Fiber Fruits/vegetables Polyunsaturated fats Monounsaturated fats Whole grain Handelsman Y, et al. Endocr Pract. 2011;17(suppl 2):1-53. Garvey WY, Lara-Castro C. J Clin Endocrinol Metab. 2004;89:

25 Physical Activity Adults with T2DM should be advised to perform at least 150 min/week of moderate-intense aerobic activity (50%-70% of maximum HR) spread over 3 days with no more than 2 consecutive days without exercising In the absence of contraindications, resistance training should be performed at least twice weekly Providers should use clinical judgment when deciding whether to screen asymptomatic patients for silent CAD High risk patients should be encouraged to start with short periods of low intensity exercise and progress slowly ADA Clinical Practice Recommendations. Diabetes Care. 2013;36 (Suppl 1):S24. HR, heart rate

26 AACE Physical Activity Recommendations Patients 150 minutes per week of moderate-intensity (ie, conversational ) exercise Flexibility and strength training Aerobic exercise (e.g., brisk walking) Cross-train Heart rate to 70% maximum (max HR = 220 age) Start slowly and build up gradually Use exercise partners, organized activities, or professional trainer to help with motivation Healthcare Professionals Exude positive attitude Evaluate for contraindications and/or limitations to increased physical activity before patient begins or intensifies exercise program Develop exercise recommendations according to individual goals and limitations Set realistic goals and schedules Handelsman Y, et al. Endocr Pract. 2011;17(suppl 2):1-53.

27 How Much Exercise Is Enough? Intensity Moderate, conversational exercise (: should be able to talk comfortably ) Heart rate at 70% of maximum (max HR = 220 age) Frequency 3-4 times per week Maintain regular schedule with realistic goals Motivation Cross-train (ie, walk, ride, swim) Use exercise partner or professional trainer or attend organized programs Reward self Health care professional team must exude positive attitude regarding importance of exercise

28 Diabetes Mellitus Reduction (%) Is it Possible to Delay the Onset of T2DM? % >5% loss 42% 58% 31% 25% 55% 41% 62% 72% Finnish-Diet+ Exercise Da Qing Diet + Exercise DPP-Lifestyle DPP-Metformin STOP-NIDDM Diabetes Prevention Clinical Trials TRIPOD XENDOS DREAM ActNOW FINNISH=Tuomilehto J, et al. N Engl J Med 2001; 344: DA QING=Pan XR, et al. Diabetes Care. 1997; 20: DPP=Diabetes Prevention Program. Nathan DM, et al. N Engl J Med 2002; 346: STOP-NIDDM=Study TO Prevent Non-Insulin-Dependent Diabetes Mellitus. Chiasson JL, et al. Lancet 2002; 359: TRIPOD=Troglitazone in the Prevention of Diabetes. Buchanan T, et al. Diabetes 2002; 51(9): XENDOS=XEnical in the Prevention of Diabetes in Obese Subjects. Torgerson JS, et al. Diabetes Care 2004; 27 (1): DREAM=Diabetes Reduction Assessment with Ramipril & Rosiglitazone Medication. Gerstein H, et al. Lancet 2006; 368:

29 Medical Complications of Obesity Pulmonary disease abnormal function obstructive sleep apnea hypoventilation syndrome Nonalcoholic fatty liver disease steatohepatitis cirrhosis Gall bladder disease Gynecologic abnormalities abnormal menses infertility polycystic ovarian syndrome Osteoarthritis Skin Gout Idiopathic intracranial hypertension Stroke Cataracts Coronary heart disease Diabetes Dyslipidemia Hypertension Severe pancreatitis Cancer breast, uterus, cervix colon, esophagus, pancreas kidney, prostate Phlebitis venous stasis

30 Reduction in Mortality with Modest Weight Loss Effects of Weight Loss in Type 2 Diabetes Every kg of weight loss is associated with 3 to 4 months of improved survival In a prospective analysis of 5000 people with type 2 diabetes, 35% reported intentional weight loss; this subgroup experienced a 25% reduction in mortality over 12 years Alternately, a 5-kg weight gain increases coronary heart disease risk by 30% Lean ME, et al. Diabet Med. 1990;7: ; Williamson DF, et al. Diabetes Care. 2000;23: Anderson JW et al. J Am Coll Nutr. 2003;22:331-9.

31

32 Diabetes Prevention Program Conclusions Lifestyle modification was most effective for individuals 60 years of age and for those with lower baseline BMI Metformin reduced the risk of developing type 2 diabetes most effectively in patients <60 years of age, and in those with a baseline BMI >35 kg/m 2 Early intervention resulted in the greatest rate of diabetes prevention/delay in all groups The Diabetes Prevention Program Research Group. New Engl J Med. 2002;346:

33 5 Keys To Successful Diabetes Self- Management Know your metabolic targets (A1C, blood pressure, lipids) Know how to attain your metabolic targets by practicing lifestyle intervention (healthy nutritional choices and daily exercise) Take your medications (be adherent to the prescribed treatment program) Do not smoke Make certain your health care provider is knowledgeable about intensive diabetes management Unger, J. Diabetes Management in Primary Care. 2 nd Ed. Lippincott. 2012

34 Two-track Approach To Reduce Risk of Diabetes Development (1) Lower glucose to prevent microvascular complications and progression to diabetes Lifestyle intervention Pharmacotherapy in highrisk patients (2) Address cardiovascular (CV) disease risk factors Lifestyle intervention Blood pressure goals: <130/80 mm Hg Calculate CV risk

35 Feasibility of Preventing Type 2 Diabetes There is a long period of glucose intolerance that precedes the development of diabetes Screening tests can identify persons at high risk There are safe, potentially effective interventions that can address modifiable risk factors: Obesity Body fat distribution Physical inactivity High blood glucose American Diabetes Association. Diabetes Care Jan; 36(Suppl 1):S11-66.

36 Advice for Exercise Drink fluids (18 ounces) 1-2 hours before exercise Stretch Include warm-up and cool-down periods of 5-10 min each Wear silica gel or air midsoles and polyester seamless socks Check for blisters before and after activity Wear ID bracelet Aerobic or resistance training beneficial Light weights and high repetitions

37 But Doc, I Can t Walk Too Far All patients Foot disease, peripheral vascular disease, arthritis Orthostatic conditions Elderly Recommend low-impact exercise: stationary bicycle, swimming, elliptical machine, stairstepper, treadmill, low-impact aerobics, weight-lifting machine Swimming, water aerobics, upper body resistance training Semi-recumbent chair and weight lifting, semi-recumbent cycling, water exercise Stretching while sitting, movement exercise (eg, tai chi, hatha yoga) Anything is better than nothing

38 Set Realistic Goals With Your Patient Goal: decrease risk of complications and improve long-term outlook Ask patient: What are your goals? Patients often want to lose ~30% of body weight (a loss of only 7% to 10% or less may be equated with failure) Advise patients to accept steady, incremental progress and emphasize that improved health not necessarily reduced weight is the goal Short-term weight loss goal (for most patients): 7% to 10% loss at 6 months Increase in muscle mass may be more important than decrease in fat mass Interim goal: maintenance Long-term goal (if desired): additional energy deficit recalculated for next weight loss goal Remind patients that reducing caloric intake and increasing physical activity are key to achieving and maintaining weight loss

39 Summary Lifestyle intervention effectively prevents diabetes and adverse cardiovascular outcomes Lifestyle alone is less effective in more obese populations Weight loss with lifestyle change is difficult to maintain long-term Ongoing behavioral support from healthcare team and/or structured support group can help patients maintain weight loss Benefits of initial weight loss are sustained even with weight regain Medical interventions are more effective when combined with lifestyle change Healthcare professionals should work with patients to set realistic goals and encourage adherence to weight loss/maintenance behaviors

40 Conditions for Success Engagement with other health team members Support at home (and at work) Patience Persistence Realism set goals The weight treatment goal is to lose 5 to 10% of current body weight over the next 6 to 12 months. Perpetual goal until BMI is 18.5 to 24.9 kg/m 2

41 Strategies for Maintaining Weight Loss From the Academy of Nutrition and Dietetics Evidence Analysis Library: Reduced calorie diet Distribute calories throughout day Portion control Avoid large meals, especially later in day Meal replacements can be helpful Other Strategies: Increasing fruits, vegetables, and low-fat dairy effective in the Weight Loss Maintenance Clinical Trial National Weight Control Registry promotes eating breakfast, physical activity (1.5 hr/day) and self-monitoring

42 Motivational Interviewing Encourage collaboration Let s put our heads together and review the options. Support autonomy and problem-solving; remember, 99% of outcomes are the patient s Develop motivation by eliciting change talk Ask open-ended, motivational questions What do you want to accomplish in this visit today? What is the most important concern to you about your diabetes right now? Miller R, Rollnick S, eds. Motivational Interviewing. New York, NY: The Guilford Press; 2002.

43 Motivational Interviewing Ask permission before giving advice Ask: May I propose a plan? or What about? Avoid: You should eat less and walk more. Approach with curiosity or invitation Say: I wonder or One option could be Invite: How about week or so trial of? or Some people with diabetes have found Miller R, Rollnick S, eds. Motivational Interviewing. New York, NY: The Guilford Press; 2002.

44 Motivational Empowerment Focus on: Optimism: I think you re onto something. Strengths: What are your strongest areas in managing your diabetes? What are you most comfortable with? Legitimizing experiences: I know what you mean about shopping when hungry. If I stop at the store on my way home from work, I always buy too much. Miller R, Rollnick S, eds. Motivational Interviewing. New York, NY: The Guilford Press; 2002.

Lifestyle Medicine. This presentation will:

Lifestyle Medicine. This presentation will: Lifestyle Medicine This presentation will: Identify barriers to lifestyle therapy and develop strategies to promote behavioral changes in patients with obesity and/or T2D. AACE = American Association of

More information

Lifestyle Medicine. This presentation will:

Lifestyle Medicine. This presentation will: Lifestyle Medicine This presentation will: Present the biological and environmental factors contributing to the obesity epidemic Discuss the lifestyle modification therapy for patients with obesity, prediabetes,

More information

Lifestyle Medicine. Elliot Sternthal, MD, FACP, FACE Chair New England AACE Diabetes Day Planning Committee

Lifestyle Medicine. Elliot Sternthal, MD, FACP, FACE Chair New England AACE Diabetes Day Planning Committee Lifestyle Medicine Elliot Sternthal, MD, FACP, FACE Chair New England AACE Diabetes Day Planning Committee Lifestyle Medicine This presentation will: Present the biological and environmental factors contributing

More information

Lifestyle Medicine. This presentation will:

Lifestyle Medicine. This presentation will: Lifestyle Medicine This presentation will: Present the biological and environmental factors contributing to the obesity epidemic Discuss the lifestyle modification therapy for patients with obesity, prediabetes,

More information

How Do We Treat Obesity? Lifestyle Intervention

How Do We Treat Obesity? Lifestyle Intervention How Do We Treat Obesity? Lifestyle Intervention Why Is Lifestyle Weight Management Important? Improved metabolic control Lower fasting blood glucose and prevent T2D Lower blood pressure and lipid profile

More information

How Do We Treat Obesity? Lifestyle Intervention

How Do We Treat Obesity? Lifestyle Intervention How Do We Treat Obesity? Lifestyle Intervention Why Is Lifestyle Weight Management Important? Improved metabolic control Lower fasting blood glucose and prevent T2D Lower blood pressure and lipid profile

More information

Effective Interventions in the Clinical Setting: Engaging and Empowering Patients. Michael J. Bloch, M.D. Doina Kulick, M.D.

Effective Interventions in the Clinical Setting: Engaging and Empowering Patients. Michael J. Bloch, M.D. Doina Kulick, M.D. Effective Interventions in the Clinical Setting: Engaging and Empowering Patients Michael J. Bloch, M.D. Doina Kulick, M.D. UNIVERSITY OF NEVADA SCHOOL of MEDICINE Sept. 8, 2011 Reality check: What could

More information

Presenter Disclosure Information

Presenter Disclosure Information Prediabetes & Type 2 Diabetes Prevention Cari Ritter, PA-C Presenter Disclosure Information In compliance with the accrediting board policies, the American Diabetes Association requires the following disclosure

More information

Metabolic Syndrome. Shon Meek MD, PhD Mayo Clinic Florida Endocrinology

Metabolic Syndrome. Shon Meek MD, PhD Mayo Clinic Florida Endocrinology Metabolic Syndrome Shon Meek MD, PhD Mayo Clinic Florida Endocrinology Disclosure No conflict of interest No financial disclosure Does This Patient Have Metabolic Syndrome? 1. Yes 2. No Does This Patient

More information

Clinical Staging for Obesity. Raj Padwal Clinical Pharmacology and General Internal Medicine University of Alberta

Clinical Staging for Obesity. Raj Padwal Clinical Pharmacology and General Internal Medicine University of Alberta Clinical Staging for Obesity Raj Padwal Clinical Pharmacology and General Internal Medicine University of Alberta Disclosures Funding: CIHR, Heart and Stroke Foundation of Canada, University Hospital Foundation.

More information

Obesity and Cancer Survivorship. Cynthia Thomson, PhD, RD Professor-Mel & Enid Zuckerman College of Public Health University of Arizona

Obesity and Cancer Survivorship. Cynthia Thomson, PhD, RD Professor-Mel & Enid Zuckerman College of Public Health University of Arizona Obesity and Cancer Survivorship Cynthia Thomson, PhD, RD Professor-Mel & Enid Zuckerman College of Public Health University of Arizona Objectives Describe the relationship between obesity, weight gain

More information

Prediabetes & Type 2 Diabetes Prevention. Jacob M. Haus, PHD

Prediabetes & Type 2 Diabetes Prevention. Jacob M. Haus, PHD Prediabetes & Type 2 Diabetes Prevention Jacob M. Haus, PHD Disclosures In compliance with the accrediting board policies, the American Diabetes Association requires the following disclosure to the participants:

More information

STATE OF THE STATE: TYPE II DIABETES

STATE OF THE STATE: TYPE II DIABETES STATE OF THE STATE: TYPE II DIABETES HENRY DRISCOLL, MD, CHIEF of ENDOCRINOLOGY MARSHALL U, CHERTOW DIABETES CENTER, HUNTINGTON VAMC HEATHER VENOY, RD, LD, CDE DIETITIAN, DIABETES EDUCATOR, CHERTOW DIABETES

More information

Part 1: Obesity. Dietary recommendations in Obesity, Hypertension, Hyperlipidemia, and Diabetes 10/15/2018. Objectives.

Part 1: Obesity. Dietary recommendations in Obesity, Hypertension, Hyperlipidemia, and Diabetes 10/15/2018. Objectives. Dietary recommendations in Obesity, Hypertension, Hyperlipidemia, and Diabetes Stephen D. Sisson MD Objectives To review dietary recommendations in the following conditions: Obesity Hypertension Diabetes

More information

Nutrition and Medicine, 2006 Tufts University School of Medicine Nutrition and Type 2 Diabetes: Learning Objectives

Nutrition and Medicine, 2006 Tufts University School of Medicine Nutrition and Type 2 Diabetes: Learning Objectives Nutrition and Medicine, 2006 Tufts University School of Medicine Nutrition and Type 2 Diabetes: Learning Objectives Margo N. Woods, D.Sc. 1. Discuss the increase in the incidence and prevalence of type

More information

Dietary recommendations in Obesity, Hypertension, Hyperlipidemia, and Diabetes. Stephen D. Sisson MD

Dietary recommendations in Obesity, Hypertension, Hyperlipidemia, and Diabetes. Stephen D. Sisson MD Dietary recommendations in Obesity, Hypertension, Hyperlipidemia, and Diabetes Stephen D. Sisson MD Objectives To review dietary recommendations in the following conditions: Obesity Hypertension Diabetes

More information

«Πατσζαρκία και Καρδιαγγειακή Νόζος»

«Πατσζαρκία και Καρδιαγγειακή Νόζος» «Πατσζαρκία και Καρδιαγγειακή Νόζος» Δημήτρης Π. Παπαδόπουλος-FESC Clinical Assist. Professor George Washington University USA Επιμελητής Καρδιολογικής Κλινικής Π.Γ.Ν.Α. «ΛΑΪΚΟ» Υπεύθυνος Αντιυπερτασικού

More information

Diabetes and Weight Management: Tools to Affect Patient Outcomes

Diabetes and Weight Management: Tools to Affect Patient Outcomes Diabetes and Weight Management: Tools to Affect Patient Outcomes Today s discussion Review the problem of diabetes and the importance of lifestyle intervention Identify current research supporting the

More information

Dr.Kamal Waheeb AlGhalayini MD, SCC Med. MSc-Card Associate professor, Consultant Cardiology. Head non-invasive lab. Vice dean for clinical affaires

Dr.Kamal Waheeb AlGhalayini MD, SCC Med. MSc-Card Associate professor, Consultant Cardiology. Head non-invasive lab. Vice dean for clinical affaires Dr.Kamal Waheeb AlGhalayini MD, SCC Med. MSc-Card Associate professor, Consultant Cardiology. Head non-invasive lab. Vice dean for clinical affaires King Abdulaziz University. Doc, I am fat because my

More information

Goals of today s talk. How to Stop Prediabetes from Becoming Diabetes. Goals of today s talk. Type 2 diabetes mellitus

Goals of today s talk. How to Stop Prediabetes from Becoming Diabetes. Goals of today s talk. Type 2 diabetes mellitus Goals of today s talk How to Stop Prediabetes from Becoming Diabetes Zara Frankel, MD Boulder Creek Family Medicine 303-720-6956 Diabetes is a devastating disease Prediabetes and diabetes are on different

More information

Donna Tomky, MSN, C-ANP, CDE, FAADE Albuquerque, New Mexico

Donna Tomky, MSN, C-ANP, CDE, FAADE Albuquerque, New Mexico Donna Tomky, MSN, C-ANP, CDE, FAADE Albuquerque, New Mexico Presented in Collaboration with New Mexico Health Care Takes On Diabetes Discuss the burden and challenges prediabetes presents in New Mexico.

More information

Access to Proven Therapies

Access to Proven Therapies Access to Proven Therapies Obesity is a life-threatening disease affecting 34% of adults in the U.S. Between 2000 and 2005, obesity increased by 24%, morbid obesity by 50%, and super obesity by 75%. 18%

More information

Prediabetes 101. What is it and what can I do about it? Intermountainhealthcare.org/diabetes

Prediabetes 101. What is it and what can I do about it? Intermountainhealthcare.org/diabetes Prediabetes 101 What is it and what can I do about it? Patient Education Intermountainhealthcare.org/diabetes What do you already know about prediabetes? Fact or Fiction? There are often no symptoms of

More information

Nutritional Recommendations for the Diabetes Managements

Nutritional Recommendations for the Diabetes Managements In the name of God Nutritional for the Diabetes Managements Zohreh Mazloom. PhD Shiraz University of Medical Sciences School of Nutrition and Food Sciences Department of Clinical Nutrition OVERVIEW Healthful

More information

Nutrition in the twenty-first century

Nutrition in the twenty-first century Nutrition in the twenty-first century Tom Sanders DSc, PhD, Emeritus Professor of Nutrition & Dietetics, Diabetes & Nutritional Sciences Research Division, King s College London, UK Europe in the 21 st

More information

Session 21: Heart Health

Session 21: Heart Health Session 21: Heart Health Heart disease and stroke are the leading causes of death in the world for both men and women. People with pre-diabetes, diabetes, and/or the metabolic syndrome are at higher risk

More information

Cardiovascular Complications of Diabetes

Cardiovascular Complications of Diabetes VBWG Cardiovascular Complications of Diabetes Nicola Abate, M.D., F.N.L.A. Professor and Chief Division of Endocrinology and Metabolism The University of Texas Medical Branch Galveston, Texas Coronary

More information

Medical Nutrition Therapy for Diabetes Mellitus. Raziyeh Shenavar MSc. of Nutrition

Medical Nutrition Therapy for Diabetes Mellitus. Raziyeh Shenavar MSc. of Nutrition Medical Nutrition Therapy for Diabetes Mellitus Raziyeh Shenavar MSc. of Nutrition Diabetes Mellitus A group of diseases characterized by high blood glucose concentrations resulting from defects in insulin

More information

Metabolic Syndrome Update The Metabolic Syndrome: Overview. Global Cardiometabolic Risk

Metabolic Syndrome Update The Metabolic Syndrome: Overview. Global Cardiometabolic Risk Metabolic Syndrome Update 21 Marc Cornier, M.D. Associate Professor of Medicine Division of Endocrinology, Metabolism & Diabetes University of Colorado Denver Denver Health Medical Center The Metabolic

More information

STAYING HEART HEALTHY PAVAN PATEL, MD CONSULTANT CARDIOLOGIST FLORIDA HEART GROUP

STAYING HEART HEALTHY PAVAN PATEL, MD CONSULTANT CARDIOLOGIST FLORIDA HEART GROUP STAYING HEART HEALTHY PAVAN PATEL, MD CONSULTANT CARDIOLOGIST FLORIDA HEART GROUP What is Heart Disease Cardiovascular Disease (CVD): Heart or Blood vessels are not working properly. Most common reason

More information

Hypertension with Comorbidities Treatment of Metabolic Risk Factors in Children and Adolescents

Hypertension with Comorbidities Treatment of Metabolic Risk Factors in Children and Adolescents Hypertension with Comorbidities Treatment of Metabolic Risk Factors in Children and Adolescents Stella Stabouli Ass. Professor Pediatrics 1 st Department of Pediatrics Hippocratio Hospital Evaluation of

More information

What s New in the Standards of Medical Care in Diabetes? Dr. Jason Kruse, DO Broadlawns Medical Center

What s New in the Standards of Medical Care in Diabetes? Dr. Jason Kruse, DO Broadlawns Medical Center What s New in the Standards of Medical Care in Diabetes? Dr. Jason Kruse, DO Broadlawns Medical Center Learning Objectives By the end of this presentation, participants should be able to: Discuss updates

More information

Objectives. Objectives. Alejandro J. de la Torre, MD Cook Children s Hospital May 30, 2015

Objectives. Objectives. Alejandro J. de la Torre, MD Cook Children s Hospital May 30, 2015 Alejandro J. de la Torre, MD Cook Children s Hospital May 30, 2015 Presentation downloaded from http://ce.unthsc.edu Objectives Understand that the obesity epidemic is also affecting children and adolescents

More information

Chronic Disease Management. Mary Rouleau, RN, RD, CDE Condition Management RN The Center

Chronic Disease Management. Mary Rouleau, RN, RD, CDE Condition Management RN The Center Chronic Disease Management Mary Rouleau, RN, RD, CDE Condition Management RN The Center Chronic Diseases Conditions that: last 1 year or more require ongoing medical attention limit activities of daily

More information

Page 2: Baker IDI. Page 4: Baker IDI. Global & Regional Obesity. High income English speaking Light Blue. Global & Regional Severe obesity

Page 2: Baker IDI. Page 4: Baker IDI. Global & Regional Obesity. High income English speaking Light Blue. Global & Regional Severe obesity Metabolic Update Patients selection and choice of procedure Professor John B Dixon MBBS, FRACGP, FRCP Edin, PhD NHMRC Senior Research Fellow Head of Clinical Obesity Research, Baker IDI Heart and Diabetes

More information

Discussion points. The cardiometabolic connection. Cardiometabolic Risk Management in the Primary Care Setting

Discussion points. The cardiometabolic connection. Cardiometabolic Risk Management in the Primary Care Setting Session #5 Cardiometabolic Risk Management in the Primary Care Setting Sonja Reichert, MD MSc FCFP FACPM Betty Harvey, RNEC BScN MScN Amanda Mikalachki, RN BScN CDE S Discussion points Whom should we be

More information

Overweight. You are part of it! Healthier, fitter, safer.

Overweight. You are part of it! Healthier, fitter, safer. Overweight You are part of it! Healthier, fitter, safer. Overweight prevention, you are part of it!... People who are overweight are at greater risk of dying prematurely from chronic health problems! Being

More information

Diabetes Day for Primary Care Clinicians Advances in Diabetes Care

Diabetes Day for Primary Care Clinicians Advances in Diabetes Care Diabetes Day for Primary Care Clinicians Advances in Diabetes Care Elliot Sternthal, MD, FACP, FACE Chair New England AACE Diabetes Day Planning Committee Welcome and Introduction This presentation will:

More information

Kerri Wade, RN, MSN, PPCNP-BC Children s Mercy APRN Annual Conference October 7, The Children's Mercy Hospital, 2016

Kerri Wade, RN, MSN, PPCNP-BC Children s Mercy APRN Annual Conference October 7, The Children's Mercy Hospital, 2016 12345 Fit-Tastic: A Tool for Combating Childhood Obesity Kerri Wade, RN, MSN, PPCNP-BC Children s Mercy APRN Annual Conference October 7, 2016 The Children's Mercy Hospital, 2016 Disclosure I am a nurse

More information

Nutritional Aspects of Obesity Management. Christy Olson MS, RD, LD, CDE

Nutritional Aspects of Obesity Management. Christy Olson MS, RD, LD, CDE Nutritional Aspects of Obesity Management Christy Olson MS, RD, LD, CDE Relevant Disclosure and Resolution Under Accreditation Council for Continuing Medical Education guidelines disclosure must be made

More information

American Diabetes Association: Standards of Medical Care in Diabetes 2015

American Diabetes Association: Standards of Medical Care in Diabetes 2015 American Diabetes Association: Standards of Medical Care in Diabetes 2015 Synopsis of ADA standards relevant to the 11 th Scope of Work under Task B.2 ASSESSMENT OF GLYCEMIC CONTROL Recommendations: Perform

More information

overweight you are part of it!... Healthier, fitter, safer... Seafarers Health Information Programme ICSW S.H.I.P.

overweight you are part of it!... Healthier, fitter, safer... Seafarers Health Information Programme ICSW S.H.I.P. overweight you are part of it!... Seafarers Health Information Programme Healthier, fitter, safer... S.H.I.P. ICSW BROCHUREA5_COR1.indd 1 24/08/2007 19:38:40 Overweight prevention, you are part of it!...

More information

Science of Obesity (I-2.28)

Science of Obesity (I-2.28) Science of Obesity (I-2.28) Dr Noha Nooh Lasheen Lecturer of Physiology Date :16 / 10 / 2016 Objectives By the end of this lecture, the student should be able to: Define energy, energy balance and obesity.

More information

Depression, anxiety, and obesity

Depression, anxiety, and obesity Depression, anxiety, and obesity 5As Team Learning modules Depression and anxiety are two prevalent mood disorders that affect Canadians, with as many as 40-70% of overweight/obese individuals at high

More information

Understanding the metabolic syndrome

Understanding the metabolic syndrome Understanding the metabolic syndrome Understanding the metabolic system Metabolic syndrome is the clustering together of a number of risk factors for heart disease, stroke and diabetes. Having one of these

More information

Health Score SM Member Guide

Health Score SM Member Guide Health Score SM Member Guide Health Score Your Health Score is a unique, scientifically based assessment of seven critical health indicators gathered during your health screening. This number is where

More information

Which Weigh to Go? Behavior and Dietary Strategies for Weight Management March 7, 2013

Which Weigh to Go? Behavior and Dietary Strategies for Weight Management March 7, 2013 Which Weigh to Go? Behavior and Dietary Strategies for Weight Management March 7, 2013 Presenter: Gary D. Foster, PhD Temple University School of Medicine Director, Center for Obesity Research and Education

More information

Diabetes is diagnosed when fasting blood glucose levels are 126 mg/dl and higher.

Diabetes is diagnosed when fasting blood glucose levels are 126 mg/dl and higher. HealthyU, a Lifestyle Medicine Initiative, was developed to provide information about wellness programs, products, plans, or services that impact the health and wellbeing of benefit eligible team members

More information

Low carbohydrate diets- do they have a place?

Low carbohydrate diets- do they have a place? Low carbohydrate diets- do they have a place? Grant Schofield Professor of Public Health AUT University, Auckland NZ @grantsnz www.facebook.com/profgrant www.profgrant.com Atherogenic dyslipidemia is [primarily]

More information

Standards of Medical Care in Diabetes 2016

Standards of Medical Care in Diabetes 2016 Standards of Medical Care in Diabetes 2016 Care Delivery Systems 33-49% of patients still do not meet targets for A1C, blood pressure, or lipids. 14% meet targets for all A1C, BP, lipids, and nonsmoking

More information

Obesity D R. A I S H A H A L I E K H Z A I M Y

Obesity D R. A I S H A H A L I E K H Z A I M Y Obesity D R. A I S H A H A L I E K H Z A I M Y Objectives Definition Pathogenesis of obesity Factors predisposing to obesity Complications of obesity Assessment and screening of obesity Management of obesity

More information

Am I at Risk for Type 2 Diabetes?

Am I at Risk for Type 2 Diabetes? Am I at Risk for Type Diabetes? Taking Steps to Lower Your Risk of Getting Diabetes On this page: What is type diabetes? Can type diabetes be prevented? What are the signs and symptoms of type diabetes?

More information

Objectives. Medical Nutrition Therapy (MNT) for Diabetes Evidence-based Recommendations. No financial disclosures

Objectives. Medical Nutrition Therapy (MNT) for Diabetes Evidence-based Recommendations. No financial disclosures Medical Nutrition Therapy (MNT) for Diabetes Evidence-based Recommendations Advances in Internal Medicine 2013 Sarah Kim, MD Assistant Clinical Professor, UCSF-SFGH No financial disclosures Objectives

More information

Objectives 10/11/2013. Diabetes- The Real Cost of Sugar. Diabetes 101: What is Diabetes. By Ruth Nekonchuk RD CDE LMNT

Objectives 10/11/2013. Diabetes- The Real Cost of Sugar. Diabetes 101: What is Diabetes. By Ruth Nekonchuk RD CDE LMNT Diabetes- The Real Cost of Sugar By Ruth Nekonchuk RD CDE LMNT Objectives To explain diabetes To explain the risks of diabetes To enumerate the cost of diabetes to our country To enumerate the cost of

More information

The National Diabetes Prevention Program in Washington State March 2012

The National Diabetes Prevention Program in Washington State March 2012 The National Diabetes Prevention Program in Washington State March 2012 Session Objectives 1. Overview of pre-diabetes. 2. Describe the Diabetes Prevention Program (DPP). 3. Eligibility for the DPP. 4.

More information

Case Study #4: Hypertension and Cardiovascular Disease

Case Study #4: Hypertension and Cardiovascular Disease Helen Jang Tara Hooley John K Rhee Case Study #4: Hypertension and Cardiovascular Disease 7. What risk factors does Mrs. Sanders currently have? The risk factors that Mrs. Sanders has are high blood pressure

More information

Pre-diabetes. Pharmacological Approaches to Delay Progression to Diabetes

Pre-diabetes. Pharmacological Approaches to Delay Progression to Diabetes Pre-diabetes Pharmacological Approaches to Delay Progression to Diabetes Overview Definition of Pre-diabetes Risk Factors for Pre-diabetes Clinical practice guidelines for diabetes Management, including

More information

Medical Nutrition Therapy Options for Adults Living with Diabetes. Jane Eyre Schuster, RD, LD, CDE Legacy Health Diabetes and Nutrition Services

Medical Nutrition Therapy Options for Adults Living with Diabetes. Jane Eyre Schuster, RD, LD, CDE Legacy Health Diabetes and Nutrition Services Medical Nutrition Therapy Options for Adults Living with Diabetes Jane Eyre Schuster, RD, LD, CDE Legacy Health Diabetes and Nutrition Services Objectives Discuss Medical Nutrition Therapy considerations

More information

Polycystic ovarian syndrome Can lifestyle modifications help?? Dr Saloni Assistant Professor, Deptt of OBG BPSGMC for Women, Khanpur Kalan

Polycystic ovarian syndrome Can lifestyle modifications help?? Dr Saloni Assistant Professor, Deptt of OBG BPSGMC for Women, Khanpur Kalan Polycystic ovarian syndrome Can lifestyle modifications help?? Dr Saloni Assistant Professor, Deptt of OBG BPSGMC for Women, Khanpur Kalan Life-long condition Hirsutism Menstrual irregularities? Pronounced

More information

Treating Type 2 Diabetes by Treating Obesity. Vijaya Surampudi, MD, MS Assistant Professor of Medicine Center for Human Nutrition

Treating Type 2 Diabetes by Treating Obesity. Vijaya Surampudi, MD, MS Assistant Professor of Medicine Center for Human Nutrition Treating Type 2 Diabetes by Treating Obesity Vijaya Surampudi, MD, MS Assistant Professor of Medicine Center for Human Nutrition 2 Center Stage Obesity is currently an epidemic in the United States, with

More information

Obesity: Pharmacologic and Surgical Management

Obesity: Pharmacologic and Surgical Management Obesity: Pharmacologic and Surgical Management ADRIENNE YOUDIM, MD, FACP ASSOCIATE PROFESSOR OF MEDICINE, UCLA ASSISTANT PROFESSOR OF MEDICINE, CEDARS SINAI MEDICAL CENTER JANUARY 2018 Defining Obesity

More information

Specific treatment for obesity will be determined by your health care provider based on:

Specific treatment for obesity will be determined by your health care provider based on: Regardless of the type or combination of obesity treatment, goal setting is an important part of any obesity treatment plan. While a person may want to lose a large amount of weight because of societal

More information

Obesity. Picture on. This is the era of the expanding waistline.

Obesity. Picture on. This is the era of the expanding waistline. Feature Raffles HealthNews The Big Raffles HealthNews Feature Picture on Obesity This is the era of the expanding waistline. Why is obesity such a big problem? Is it just a personal matter? What do the

More information

UNDERSTANDING TYPE 2 DIABETES

UNDERSTANDING TYPE 2 DIABETES 1 UNDERSTANDING TYPE 2 DIABETES PUTTING IT INTO REMISSION WITH A LOW-CARB HIGH-FAT DIET Jacqueline A. Eberstein, R.N. Director of Protocol, HEALcare The Scope of the Challenge 2 The People The Scope of

More information

Disclosures OBESITY. Overview. Obesity: Definition. Prevalence of Obesity is Rising. Obesity as a Risk Factor. None

Disclosures OBESITY. Overview. Obesity: Definition. Prevalence of Obesity is Rising. Obesity as a Risk Factor. None Disclosures None OBESITY Florencia Halperin, M.D. Medical Director, Program for Management Brigham and Women s Hospital Instructor in Medicine, Harvard Medical School Overview Obesity: Definition Definition

More information

Type 2 Diabetes in Adolescents

Type 2 Diabetes in Adolescents Type 2 Diabetes in Adolescents Disclosures Paid consultant, Eli Lilly, Inc, Pediatric Type 2 Diabetes Clinical Trials Outline The burden of diabetes Treatment and Prevention Youth Diabetes Prevention Clinic

More information

Laboratory analysis of the obese child recommendations and discussion. MacKenzi Hillard May 4, 2011

Laboratory analysis of the obese child recommendations and discussion. MacKenzi Hillard May 4, 2011 Laboratory analysis of the obese child recommendations and discussion MacKenzi Hillard May 4, 2011 aka: What to do with Fasting Labs The Obesity Epidemic The prevalence of obesity in adolescents has tripled

More information

Macronutrients and Dietary Patterns for Glucose Control

Macronutrients and Dietary Patterns for Glucose Control 제 20 회대한당뇨병학회춘계학술대회 Macronutrients and Dietary Patterns for Glucose Control 2017.5.13 서울대학교병원임정현 Conflict of interest disclosure None Committee of Scientific Affairs Contents Review of Nutrition Recommendation

More information

Coach on Call. Thank you for your interest in Lifestyle Changes as a Treatment Option. I hope you find this tip sheet helpful.

Coach on Call. Thank you for your interest in Lifestyle Changes as a Treatment Option. I hope you find this tip sheet helpful. It was great to talk with you. Thank you for your interest in. I hope you find this tip sheet helpful. Please give me a call if you have more questions about this or other topics. As your UPMC Health Plan

More information

A N A C P S P E C I A L R E P O R T. Understanding and Managing Your. Triglycerides

A N A C P S P E C I A L R E P O R T. Understanding and Managing Your. Triglycerides A N A C P S P E C I A L R E P O R T Understanding and Managing Your Triglycerides What are Triglycerides? Triglycerides are one of several types of fat in your body, and the most common of them all. Along

More information

Screening Results. Juniata College. Juniata College. Screening Results. October 11, October 12, 2016

Screening Results. Juniata College. Juniata College. Screening Results. October 11, October 12, 2016 Juniata College Screening Results Juniata College Screening Results October 11, 2016 & October 12, 2016 JUNIATA COLLEGE The J.C. Blair Hospital CARES team screened 55 Juniata College employees on October

More information

Obesity and Cancer Survivorship: Where are we in Providing Care? Cynthia Thomson, PhD, RD Mary Koithan, PhD, RN, CNS-BC

Obesity and Cancer Survivorship: Where are we in Providing Care? Cynthia Thomson, PhD, RD Mary Koithan, PhD, RN, CNS-BC Obesity and Cancer Survivorship: Where are we in Providing Care? Cynthia Thomson, PhD, RD Mary Koithan, PhD, RN, CNS-BC Objectives This webinar will help you: Describe the relationship between obesity,

More information

The Growing Epidemic of Diabetes

The Growing Epidemic of Diabetes The Ad Hoc Group for Medical Research Luncheon Briefing for Senate and House Staff The Growing Epidemic of Diabetes and What the NIH Is Doing About It Griffin. Rodgers, M.D., M.A.C.. Director National

More information

Established Risk Factors for Coronary Heart Disease (CHD)

Established Risk Factors for Coronary Heart Disease (CHD) Getting Patients to Make Small Lifestyle Changes That Result in SIGNIFICANT Improvements in Health - Prevention of Diabetes and Obesity for Better Health Maureen E. Mays, MD, MS, FACC Director ~ Portland

More information

Janice Lazear, DNP, FNP-C, CDE DIAGNOSIS AND CLASSIFICATION OF DIABETES

Janice Lazear, DNP, FNP-C, CDE DIAGNOSIS AND CLASSIFICATION OF DIABETES Janice Lazear, DNP, FNP-C, CDE DIAGNOSIS AND CLASSIFICATION OF DIABETES Objectives u At conclusion of the lecture the participant will be able to: 1. Differentiate between the classifications of diabetes

More information

CHOLESTEROL GUIDELINES

CHOLESTEROL GUIDELINES CHOLESTEROL GUIDELINES High cholesterol and lipid levels can significantly increase a person's risk of developing chest pain, heart attack, and stroke. Fortunately, a number of effective treatment options

More information

DIABETES. A growing problem

DIABETES. A growing problem DIABETES A growing problem Countries still grappling with infectious diseases such as tuberculosis, HIV/AIDS and malaria now face a double burden of disease Major social and economic change has brought

More information

Common Diabetes-related Terms

Common Diabetes-related Terms Common Diabetes-related Terms A1C An A1C test measures a person's average blood glucose level over two to three months. Hemoglobin is the part of a red blood cell that carries oxygen to the cells and sometimes

More information

Park Hill Seventh-day Adventist Church. Journey To Wellness

Park Hill Seventh-day Adventist Church. Journey To Wellness Park Hill Seventh-day Adventist Church Journey To Wellness A Journey to Wellness Defining Health Health is a state of complete physical, mental, and social well-being, and not merely the absence of disease

More information

The Diabetes Prevention Program: Call for Action

The Diabetes Prevention Program: Call for Action The Diabetes Prevention Program: Call for Action Osama Hamdy, MD, PhD, FACE Medical Director, Obesity Clinical Program, Director of Inpatient Diabetes Management, Joslin Diabetes Center Harvard Medical

More information

10/3/2016. SUPERSIZE YOUR KNOWLEDGE OF the CARDIAC DIET. What is a cardiac diet. If it tastes good, spit it out!!

10/3/2016. SUPERSIZE YOUR KNOWLEDGE OF the CARDIAC DIET. What is a cardiac diet. If it tastes good, spit it out!! SUPERSIZE YOUR KNOWLEDGE OF the CARDIAC DIET What is a cardiac diet If it tastes good, spit it out!! 2 1 Heart healthy diet includes: Limiting saturated fat Including unsaturated fats Including omega 3

More information

Obesity Management in Patients with Diabetes Jamy D. Ard, MD Sunday, February 11, :15 a.m. 11:00 a.m.

Obesity Management in Patients with Diabetes Jamy D. Ard, MD Sunday, February 11, :15 a.m. 11:00 a.m. Obesity Management in Patients with Diabetes Jamy D. Ard, MD Sunday, February 11, 2018 10:15 a.m. 11:00 a.m. Type 2 diabetes mellitus (T2DM) is closely associated with obesity, primarily through the link

More information

MANAGING THE PRE-DIABETIC PATIENT

MANAGING THE PRE-DIABETIC PATIENT Managing the PreDiabetic Patient CAPA 2012 2 Key Questions MANAGING THE PRE-DIABETIC PATIENT Ingrid Lopes, DO 1. What is pre-diabetes and is it a disease? 2. What is the metabolic key? 3. When and how

More information

Page 2: Baker IDI. Page 4: Baker IDI. Global & Regional Obesity. High income English speaking Light Blue. Global & Regional Severe obesity

Page 2: Baker IDI. Page 4: Baker IDI. Global & Regional Obesity. High income English speaking Light Blue. Global & Regional Severe obesity Metabolic Surgery Update Patients selection and choice of procedure Professor John B Dixon MBBS, FRACGP, FRCP Edin, PhD NHMRC Senior Research Fellow Head of Clinical Obesity Research, Baker IDI Heart and

More information

WEIGHT LOSS SURGERY A Primer on Current Options and Outcomes. Caitlin A. Halbert DO, MS, FACS, FASMBS April 5, 2018

WEIGHT LOSS SURGERY A Primer on Current Options and Outcomes. Caitlin A. Halbert DO, MS, FACS, FASMBS April 5, 2018 WEIGHT LOSS SURGERY A Primer on Current Options and Outcomes Caitlin A. Halbert DO, MS, FACS, FASMBS April 5, 2018 A Little Bit About Me Bariatric Surgical Services Reflux Surgery General Surgery Overview

More information

Metabolic Syndrome. Bill Roberts, M.D., Ph.D. Professor of Pathology University of Utah

Metabolic Syndrome. Bill Roberts, M.D., Ph.D. Professor of Pathology University of Utah Metabolic Syndrome Bill Roberts, M.D., Ph.D. Professor of Pathology University of Utah Objectives Be able to outline the pathophysiology of the metabolic syndrome Be able to list diagnostic criteria for

More information

Clinical Care Performance. Financial Year 2012 to 2018

Clinical Care Performance. Financial Year 2012 to 2018 Clinical Care Performance Financial Year 2012 to 2018 SHP Clinical Care Performance Diabetes Mellitus Hyperlipidemia Hypertension Diabetes Mellitus Find out how our patients are doing for: HbA1C HbA1c

More information

Interdisciplinary Certification in Obesity and Weight Management Detailed Content Outline

Interdisciplinary Certification in Obesity and Weight Management Detailed Content Outline 1. Patient Assessment and Development of Treatment Plan (35 Items) A. Patient History and Current Status 1. Collect patient assessment information: a. weight history, including development genetics growth

More information

Your Name & Phone Number Here! Longevity Index

Your Name & Phone Number Here! Longevity Index Your Name & Phone Number Here! Longevity Index Your Health Risk Analysis is based on a variety of medical and scientific data from organizations such as the American Heart Association, American Dietetic

More information

Treating Patients with PRE- DIABETES David Doriguzzi, PA-C First Valley Medical Group. Learning Objectives. Background

Treating Patients with PRE- DIABETES David Doriguzzi, PA-C First Valley Medical Group. Learning Objectives. Background Treating Patients with PRE- DIABETES David Doriguzzi, PA-C First Valley Medical Group Learning Objectives To accurately make the diagnosis of pre-diabetes/metabolic syndrome To understand the prevalence

More information

Impact of Physical Activity on Metabolic Change in Type 2 Diabetes Mellitus Patients

Impact of Physical Activity on Metabolic Change in Type 2 Diabetes Mellitus Patients 2012 International Conference on Life Science and Engineering IPCBEE vol.45 (2012) (2012) IACSIT Press, Singapore DOI: 10.7763/IPCBEE. 2012. V45. 14 Impact of Physical Activity on Metabolic Change in Type

More information

Why Screen at 23? What can YOU do?

Why Screen at 23? What can YOU do? Why Screen at 23? Every 1 in 2 Asian American adults has diabetes or prediabetes. More than half of Asian Americans did not know they have type 2 diabetes or prediabetes. Asian Americans can develop diabetes

More information

Obesity and the Metabolic Syndrome in Developing Countries: Focus on South Asians

Obesity and the Metabolic Syndrome in Developing Countries: Focus on South Asians Obesity and the Metabolic Syndrome in Developing Countries: Focus on South Asians Anoop Misra Developing countries, particularly South Asian countries, are witnessing a rapid increase in type 2 diabetes

More information

Dr Aftab Ahmad Consultant Diabetologist at Royal Liverpool University Hospital Regional Diabetes Network Lead

Dr Aftab Ahmad Consultant Diabetologist at Royal Liverpool University Hospital Regional Diabetes Network Lead Dr Aftab Ahmad Consultant Diabetologist at Royal Liverpool University Hospital Regional Diabetes Network Lead Today s Presentation HbA1c & diagnosing Diabetes What is Impaired Glucose & IGR? Implications

More information

Am I at Risk for Type 2 Diabetes?

Am I at Risk for Type 2 Diabetes? NATIONAL DIABETES INFORMATION CLEARINGHOUSE Am I at Risk for Type 2 Diabetes? Taking Steps to Lower Your Risk of Getting Diabetes U.S. Department of Health and Human Services National Institutes of Health

More information

Cardiovascular Disease Diet & Lifestyle Katherine Tomaino Dietetic Intern Sodexo Allentown Dietetic Internship

Cardiovascular Disease Diet & Lifestyle Katherine Tomaino Dietetic Intern Sodexo Allentown Dietetic Internship Cardiovascular Disease Diet & Lifestyle Katherine Tomaino Dietetic Intern Sodexo Allentown Dietetic Internship http://www.sogoodblog.com/wp-content/uploads/2012/02/oreo1.jpg 2 Oreo Cookies = 100 kcal +

More information

Why Do We Care About Prediabetes?

Why Do We Care About Prediabetes? Why Do We Care About Prediabetes? Complications of Diabetes Diabetic Retinopathy Leading cause of blindness in adults 1,2 Diabetic Nephropathy Leading cause of Kidney failure Stroke 2- to 4-fold increase

More information

Clinical Practice Guidelines for Diabetes Management

Clinical Practice Guidelines for Diabetes Management Clinical Practice Guidelines for Diabetes Management Diabetes is a disease in which blood glucose levels are above normal. Over the years, high blood glucose damages nerves and blood vessels, which can

More information

Energy Balance Equation

Energy Balance Equation Energy Balance Equation Intake Expenditure Hunger Satiety Nutrient Absorption Metabolic Rate Thermogenesis Activity Eat to Live! Live to Eat! EAT TO LIVE Intake = Expenditure Weight Stable LIVE TO EAT

More information

BCH 445 Biochemistry of nutrition Dr. Mohamed Saad Daoud

BCH 445 Biochemistry of nutrition Dr. Mohamed Saad Daoud BCH 445 Biochemistry of nutrition Dr. Mohamed Saad Daoud 1 Energy Needs & Requirements Food is the only source of body which undergoes Metabolism and liberate / Generates Energy required for vital activities

More information